Skip to content

Influence of Anesthetic Temperature on Cephalad Sensory Blockade With Spinal Anesthesia

Influence of Anesthetic Temperature on Cephalad Sensory Blockade With Spinal Anesthesia for Cesarean Delivery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00815022
Acronym
ATOCEB
Enrollment
400
Registered
2008-12-29
Start date
2008-12-31
Completion date
2012-12-31
Last updated
2014-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Delivery

Keywords

Temperature, Spinal anesthesia, Cesarean section, Cephalad sensory blockade, Regional anesthesia

Brief summary

Several factors influence the extension of anesthetic mixture during spinal anesthesia including anesthetic gravity, body position, drug volume, and drug-delivering velocity. However, the effect of temperature of anesthetic mixture on the cephalad sensory blockade is hitherto unknown. The investigators hypothesized that different temperatures of the anesthetic mixture had different velocity of extension after spinal anesthesia. In addition, previous studies suggest that parturients have relative higher sensitivity to temperature. Herein the investigators proposed that the temperature of anesthetic mixture had more extensive effect on the cephalad sensory blockade with spinal anesthesia for cesarean delivery.

Interventions

DRUGbupivacaine/fentanyl/morphine

Hyperbaric bupivacaine 12 mg, fentanyl 10 microg and morphine 200 microg

Sponsors

Nanjing Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. Nulliparous women 2. \> 18 years and \< 45 years

Exclusion criteria

1. Allergy to opioids, a history of the use of centrally-acting drugs of any sort, chronic pain and psychiatric diseases records 2. Participants younger than 18 years or older than 45 years 3. Those who were not willing to or could not finish the whole study at any time 4. Alcohol addictive or narcotic dependent patients 5. Subjects with a nonvertex presentation 6. Diagnosed diabetes mellitus and pregnancy-induced hypertension 7. Twin gestation and breech presentation 8. Pregnant fever

Design outcomes

Primary

MeasureTime frame
Maximum cephalad sensory blockade to pinprick, cold and touchFrom the delivery of anesthetic mixture to 15 min immediate after spinal anesthesia

Secondary

MeasureTime frame
Velocity of the sensory blockade at identical body positionFrom the delivery of anesthetic mixture to 15 min immediate after spinal anesthesia
The total dose of phenylephrine required to maintain baseline arterial blood pressureFrom the delivery of anesthetic mixture to 25 min after spinal anesthesia
Time interval of the occurrence of the hypotensionFrom the delivery of the anesthetic mixture to 25 min after spinal anesthesia

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026